CORCEPT THERAPEUTICS INC Variable Lease, Cost
CORCEPT THERAPEUTICS INC (CORT) reported Variable Lease, Cost of $400.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-07-29
- CORCEPT THERAPEUTICS INC variable lease, cost for the quarter ending 2026-06-30 was $400.00K, a 100.00% increase year-over-year.
- CORCEPT THERAPEUTICS INC variable lease, cost for the quarter ending 2026-03-31 was $300.00K, a 25.00% decline year-over-year.
- CORCEPT THERAPEUTICS INC variable lease, cost for the quarter ending 2025-12-31 was -$500.00K.
- CORCEPT THERAPEUTICS INC variable lease, cost for the quarter ending 2025-09-30 was $300.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $400.00K 10-Q · filed 2026-07-29 | $700.00K 10-Q · filed 2026-07-29 | $200.00K derived: sum of 3 quarters · filed 2026-07-29 | $500.00K derived: sum of 4 quarters · filed 2026-07-29 | |
| 2026-03-31 | $300.00K 10-Q · filed 2026-04-30 | -$200.00K derived: sum of 2 quarters · filed 2026-04-30 | $100.00K derived: sum of 3 quarters · filed 2026-04-30 | $300.00K derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-12-31 | -$500.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-04-30 | -$200.00K derived: sum of 2 quarters · filed 2026-04-30 | $0.00 derived: sum of 3 quarters · filed 2026-07-29 | $400.00K 10-Q · filed 2026-04-30 | $1.20M 10-K · filed 2026-02-24 |
| 2025-09-30 | $300.00K 10-Q · filed 2025-11-04 | $500.00K derived: sum of 2 quarters · filed 2026-07-29 | $900.00K 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | $200.00K 10-Q · filed 2026-07-29 | $600.00K 10-Q · filed 2026-07-29 | |||
| 2025-03-31 | $400.00K 10-Q · filed 2025-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |